Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
The kit is developed for quantitative detection of natural and recombinant human IFN-gamma in serum, plasma and cell culture supernatants.
It is suitable for potency assay of mAbs, CAR-T/NK cell therapy.
This Assay has been anchored to NlBSC/WHO standards (Code: 87/586), ClinMax ELISA Kit: NIBSC/WHO Mass Conversion Factor is 1.
It is for research use only.
| Assay Type | Sandwich-ELISA |
| Analyte | IFN-γ |
| Format | 96-wells plate breakable into 12 x 8 wells strips |
| Reactivity | Human |
| Sensitivity | 20 pg/mL |
| Assay Time | 1.75 hr |
| Sample volume | 50 μL |
| Range | 54.7 pg/mL-3500 pg/mL |
| Sample Type | Cell Culture Supernatants, Plasma, Serum. |
| NIBSC Code | 87/586 |
Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.
For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was cal-culated based on the results of the standard curve. The minimum detectable con-centration of IFN-γ is less than 20 pg/mL.
Human peripheral blood mononuclear cells (PBMCs) obtained were plated at a density of 1 × 10⁶ cells/mL in complete RPMI 1640 medium containing 10% fetal bovine serum, 2 mM L-glutamine, and antibiotic supplements (penicillin 100 U/mL with streptomycin sulfate 100 μg/mL). Following a 5-day incubation period, experimental groups were either maintained as untreated controls or stimulated with 10 μg/mL phytohemagglutinin (PHA). Subsequent analysis involved quantitative measurement of IFN-γ concentrations in collected culture supernatants using standardized immunoassays.
Ten replicates of each of three samples containing different IFN-γ concentrations were tested in one assay. Acceptable criteria: CV＜10%.
Three samples containing different concentrations of IFN-γ were tested in independent assays. Acceptable criteria: CV<15%.
Recombinant IFN-γ was spiked into three human serum samples, and then analyzed. The average recovery of IFN-γ for serum samples is 108.9%.
| ID | Components | Size |
| CEA245-C01 | Pre-coated Anti-IFN-γ Antibody Microplate | 1 plate (8×12 strips) |
| CEA245-C02 | Human IFN-γ Standard | 35 ng×2 |
| CEA245-C03 | Biotin-Anti-IFN-γ Antibody | 25 μg |
| CEA245-C04 | Biotin-Antibody Dilution Buffer | 8 mL |
| CEA245-C05 | Streptavidin-HRP Con. Solution | 500 μL |
| CEA245-C06 | Streptavidin-HRP Dilution Buffer | 15 mL |
| CEA245-C07 | 20×Washing Buffer | 50 mL |
| CEA245-C08 | Sample Dilution Buffer | 15 mL×2 |
| CEA245-C09 | Substrate Solution | 12 mL |
| CEA245-C10 | Stop Solution | 6 mL |
Price(USD) : $565.00
Explore our catalog of therapeutic antibody solutions to find the right products for you! We are dedicated to delivering solutions designed to help you drive innovation and push the boundaries of what therapeutic antibodies can be.
We offer a wide range of cell and gene therapy solutions starting from discovery to the clinic. Explore our wide range of proteins, antibodies, kits, and other assays to accelerate the development of your cell and gene therapy.
Organoid Toolbox is a collection of organoid solutions including ready-to-use organoids, organoid differentiation kits, and a variety of services to accelerate the progress of your drug development project.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2， CD133, GPRC5D，CCR8, CCR5, etc.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To support ADC research, we offer a comprehensive range of products and services covering early discovery, CMC quality control, and both preclinical and clinical development. Our solutions help researchers accelerate innovation and optimize ADC design for maximum therapeutic impact.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
Comprehensive cytokine targets including interleukins, growth factors, chemokines, TNFs, etc. are expressed by HEK293 to ensure their natural structure. Their high purity is verified by SDS-PAGE/HPLC/SEC-MALS and high bioactivity is verified by ELISA/SPR/BLI.
Aneuro provides comprehensive tools for neuroscience research, including neuroscience proteins, pre-formed fibrils (PFFs), neural antibodies, neural factors, and more—aiming to accelerate disease modeling, drug screening, and neural mechanism studies.
This web search service is supported by Google Inc.
A-Z
